67 results
6-K
EX-2
BLRX
BioLineRx Ltd.
15 Aug 24
BioLineRx Reports Second Quarter 2024 Financial Results and Recent Corporate
7:06am
that infiltrated Israel’s southern border and other areas within the country, attacking civilians and military targets while simultaneously launching … portions of southern Lebanon, has attacked military and civilian targets in Northern Israel, to which Israel has responded, and the Islamic Republic
6-K
EX-3
BLRX
BioLineRx Ltd.
15 Aug 24
BioLineRx Reports Second Quarter 2024 Financial Results and Recent Corporate
7:06am
based on defined sales targets of motixafortide in the Territory. Additionally, we are eligible to receive tiered, double-digit royalties (ranging from 10 … infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive
6-K
EX-99.2
BLRX
BioLineRx Ltd.
28 May 24
BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate
7:11am
organization that infiltrated Israel’s southern border and other areas within the country, attacking civilians and military targets while simultaneously … that controls large portions of southern Lebanon, has attacked military and civilian targets in Northern Israel, to which Israel has responded, and the Islamic
6-K
EX-99.3
BLRX
BioLineRx Ltd.
28 May 24
BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate
7:11am
based on defined sales targets of motixafortide in the Territory. Additionally, we are eligible to receive tiered, double-digit royalties (ranging from 10 … infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched
424B5
BLRX
BioLineRx Ltd.
1 Apr 24
Prospectus supplement for primary offering
10:30am
southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks
20-F/A
zh5s8 8j5drh1zn
26 Mar 24
Annual report (foreign) (amended)
4:57pm
F-3
zcvuayu379a8b mu
29 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-99
zqe gg4wx
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
6-K
EX-99
jlrgeny0twj
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
6-K
EX-99
b18 glwor
12 Oct 23
BioLineRx Announces Closing of Exclusive License Agreement to Motixafortide
7:14am
6-K
EX-99
crkes9xaj9ua ol
30 Aug 23
BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate
7:15am
6-K
EX-99
ijrb5j 3nhunclj7kis7
30 Aug 23
BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate
7:15am
6-K
y514lv0ul1m
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
ckmhdeyq
15 Sep 22
Current report (foreign)
8:39am
6-K
EX-99
5in3m xmc8dz
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-10.1
v1f8g pfpm45hpx
3 Sep 21
Current report (foreign)
4:30pm
6-K
EX-99
jm5d7 rel0t5
16 Dec 20
Current report (foreign)
8:00am